Geron Corporation(NASDAQ:GERN) 
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for hematologic myeloid malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation ...
Website: http://www.geron.com
Founded: 1990
Full Time Employees: 45
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.45
H 1.47
L 1.33
C 1.38
V 14,551,870
10EMA 1.38
20EMA 1.38
60EMA 1.38
120EMA 1.38
250EMA 1.38